Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3511 AL 3525

Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease

Brandt J, Buchholz A, Henry-Barron B, Vizthum D, Avramopoulos D, Cervenka MC.

J Alzheimers Dis. 2019;68(3):969-981. doi: 10.3233/JAD-180995.

Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study

Tsuno N, Mori T, Ishikawa I, Bando N, Park H, Matsumoto Y, Mori I, Tanaka M, Hirano T, Nakamura Y.

Geriatr Gerontol Int. 2019 Jul;19(7):571-576. doi: 10.1111/ggi.13644. Epub 2019 Mar 12.

Diet and Inflammation in Cognitive Ageing and Alzheimer's Disease

McGrattan AM, McGuinness B, McKinley MC, Kee F, Passmore P, Woodside JV, McEvoy CT.

Curr Nutr Rep. 2019 Jun;8(2):53-65. doi: 10.1007/s13668-019-0271-4.

Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training

Karran M, Guerrero-Berroa E, Schmeidler J, Lee PG, Alexander N, Nabozny M, West RK, Beeri MS, Sano M, Silverman JM.

J Alzheimers Dis. 2019;69(2):401-411. doi: 10.3233/JAD-180952.

Rapid Reversal of Cognitive Decline, Olfactory Dysfunction, and Quality of Life Using Multi-Modality Photobiomodulation Therapy: Case Report

Salehpour F, Hamblin MR, DiDuro JO.

Photobiomodul Photomed Laser Surg. 2019 Mar;37(3):159-167. doi: 10.1089/photob.2018.4569.

Alzheimer's disease: risk factors and potentially protective measures

Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG.

J Biomed Sci. 2019 May 9;26(1):33. doi: 10.1186/s12929-019-0524-y.

Mood, lifestyle and cardiovascular risk factors among older caregivers of patients with Alzheimer's disease dementia: a case-control study

Madaleno TR, Moriguti JC, Ferriolli E, De Carlo MMRP, Lima NKC.

Aging Clin Exp Res. 2019 Nov;31(11):1609-1614. doi: 10.1007/s40520-019-01212-8. Epub 2019 May 9.

Intravenous immunoglobulins for Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease: A systematic review with meta-analysis

Liu J, Wang LN.

Expert Rev Neurother. 2019 Jun;19(6):475-480. doi: 10.1080/14737175.2019.1620106. Epub 2019 May 23.

Prevention and Treatment of Alzheimer's Disease: Biological Mechanisms of Exercise

McGurran H, Glenn JM, Madero EN, Bott NT.

J Alzheimers Dis. 2019;69(2):311-338. doi: 10.3233/JAD-180958.

Effects of brain training on brain blood flow (The Cognition and Flow Study-CogFlowS): protocol for a feasibility randomised controlled trial of cognitive training in dementia

Beishon L, Evley R, Panerai RB, Subramaniam H, Mukaetova-Ladinska E, Robinson T, Haunton V.

BMJ Open. 2019 May 22;9(5):e027817. doi: 10.1136/bmjopen-2018-027817.

Comparison between physical and cognitive treatment in patients with MCI and Alzheimer's disease

Fonte C, Smania N, Pedrinolla A, Munari D, Gandolfi M, Picelli A, Varalta V, Benetti MV, Brugnera A, Federico A, Muti E, Tamburin S, Schena F, Venturelli M.

Aging (Albany NY). 2019 May 24;11(10):3138-3155. doi: 10.18632/aging.101970.

Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence

Lejri I, Agapouda A, Grimm A, Eckert A.

Oxid Med Cell Longev. 2019 May 12;2019:9695412. doi: 10.1155/2019/9695412. eCollection 2019.

The effect of nonpharmacologic therapy on global cognitive functions in patients with Alzheimer's disease: an updated meta-analysis of randomized controlled trials

Wei S, Mai Y, Peng W, Ma J, Sun C, Li G, Liu Z.

Int J Neurosci. 2020 Jan;130(1):28-44. doi: 10.1080/00207454.2019.1638377. Epub 2019 Oct 25.

Long-Term Impact of Intelligent Monitoring Technology on People with Cognitive Impairment: An Observational Study

Lazarou I, Stavropoulos TG, Meditskos G, Andreadis S, Kompatsiaris IY, Tsolaki M.

J Alzheimers Dis. 2019;70(3):757-792. doi: 10.3233/JAD-190423.

The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis

Cui CC, Sun Y, Wang XY, Zhang Y, Xing Y.

Medicine (Baltimore). 2019 Jul;98(27):e16091. doi: 10.1097/MD.0000000000016091.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias